07:15 AM EDT, 04/04/2024 (MT Newswires) -- A US court ruled against Moderna ( MRNA ) in a patent infringement case by Arbutus (ABUS) over its COVID-19 vaccines, Reuters reported Wednesday.

US District Judge Mitchell Goldberg interpreted the patents in ways that favored Arbutus' case and hurt Moderna ( MRNA )', Reuters reported.

Arbutus sued Moderna ( MRNA ) in 2022, claiming the company's COVID-19 vaccine impinged on its patents for lipid nanoparticles that shield the vaccine's mRNA from the body's immune system.

Moderna ( MRNA ) and Arbutus did not immediately respond to MT Newswires' requests for comment.

Moderna ( MRNA ) shares was marginally higher, while shares of Arbutu were flat, and shares of its parent company Roivant (ROIV) gained in recent premarket trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 101.29, Change: +0.08, Percent Change: +0.08